Braingaze — Seed · €1.5M

Braingaze, a University of Barcelona and ICREA spin-off using patented eye-micromovement biomarkers, casual gaming and deep learning for cognitive health, raised €1.5 million led by London-based RYSE Asset Management. The money funds clinical and commercial development of its diagnostic and therapeutic solutions for ADHD, autism spectrum disorder, Alzheimer's and mild cognitive impairment.